Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine-Reference-Cited by-同舟云学术

Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine

Published:2017-09-28 Issue:3 Volume:28 Page:177-186
ISSN:1537-6516
Container-title:Toxicology Mechanisms and Methods
language:en
Short-container-title:Toxicology Mechanisms and Methods

Author:

Katz Daniel P.¹,Majrashi Mohammed¹²,Ramesh Sindhu¹,Govindarajulu Manoj¹,Bhattacharya Dwipayan¹,Bhattacharya Subhrajit¹,Shlghom Aimen³,Bradford Chastity³,Suppiramaniam Vishnu¹,Deruiter Jack¹,Clark C. Randall¹,Dhanasekaran Muralikrishnan¹

Affiliation:

1. Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA;

2. Department of Pharmacology, Faculty of Medicine, Jeddah University, Jeddah, KSA;

3. Department of Biology, College of Arts and Sciences, Tuskegee University, Tuskegee, AL, USA

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15376516.2017.1376024

Reference58 articles.

1. Roles of heat shock factors in gametogenesis and development

2. Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum

3. [13] Catalase in vitro

4. Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment

5. Piperazine compounds as drugs of abuse

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic Protocols, Structural Activity Relationship, and Biological Activity of Piperazine and its Derivatives;Medicinal Chemistry;2024-10

2. The medicinal chemistry of piperazines: A review;Chemical Biology & Drug Design;2024-06

3. Validating the anti-lymphoma pharmacodynamic actions of the endocannabinoids on canine non-Hodgkin lymphoma;Life Sciences;2023-08

4. Piperazine Designer Drugs of Abuse;Handbook of Substance Misuse and Addictions;2022

5. 1-Benzylpiperazine and other piperazine-based stimulants;Novel Psychoactive Substances;2022